Category: Uncategorized

26

Nov2019
KUALA LUMPUR: Twenty months after sofosbuvir, the generic Hepatitis C drug was brought into Malaysia through compulsory licensing, only some 4,500 patients have been treated, says the Health Ministry. It admitted that this initial stage of setting the stage for screening and treatment had been saddled with many challenges. But a lot ... Read More
November 26, 2019Hepcasia Administrator